SEC Form 4 · accession 0001104659-15-001879

Radius Health, Inc. · RDUS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Director · 10% Owner

Period of report

Jan 8, 2015

Accepted (ET)

Jan 12, 2015 · 4:40 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001428522

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jan 8, 2015	J	389,331	—	D	1,167,997	I	By Fund
Common Stock^F3	holding	—	—		—	1,794,983	I	By Fund
Common Stock^F4	holding	—	—		—	871,851	I	By Fund

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Stock Warrant^F1,F2	$2.694	Jan 8, 2015	J	89,261	D	Apr 23, 2013	Apr 23, 2018	Common Stock	89,261	267,786	I

F1Reflects a distribution by F2 Bioscience III, L.P. ("F2 Bioscience III") to a limited partner pursuant to a discretionary election.
F2The reported securities are owned directly by F2 Bioscience III. F2 Biosciences GP Ltd. ("F2 GP") is the General Partner of F2 Bioscience III. The reporting person is a member of F2 GP. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.
F3The reported securities are owned directly by F2 Bioscience IV L.P. ("F2 Bioscience IV"). F2 Bioscience IV GP Ltd. is the General Partner of F2 Bioscience IV. The members of F2 Bioscience IV GP Ltd are Katherine Priestley and Globeways Holdings Limited. The reporting person is a beneficial owner of Globeways Holdings Limited. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.
F4The reported securities are owned directly by F2 Bio Ventures V L.P. ("F2 Bio"). F2 Bio Ventures GP Ltd is General Partner of F2 Bio. The sole member of F2 Bio Ventures GP Ltd is Globeways Holdings Limited. The reporting person is a beneficial owner of Globeways Holdings Limited. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.